Live recombinant vector vaccines for veterinary use - Scientific guideline

VeterinaryScientific guidelines

Swedish is available via eTranslation, the European Commission's machine translation service.

Translate to Swedish | Important information about machine translation

This guidelines provides guidance on the data to be submitted in the marketing authorisation application for the veterinary live recombinant vector vaccines. 

Keywords: Live, recombinant vector vaccine, veterinary

Current version

Guideline on live recombinant vector vaccines for veterinary use - Revision 1

Adopted Reference Number: EMA/CVMP/IWP/390313/2023 Legal effective date:

English (EN) (224.05 KB - PDF)

Först publicerad:
Visa

Revision 1

Draft guideline on live recombinant vector vaccines for veterinary use - Revision 1

Draft: consultation closed Consultation dates: to Reference Number: EMA/CVMP/IWP/390313/2023 Summary:

This guideline provides guidance on the data to be submitted in the marketing authorisation application for the veterinary live recombinant vector vaccines. 

Comments should be provided using this template. The completed comments form should be sent IWP@ema.europa.eu

English (EN) (236.82 KB - PDF)

Först publicerad:
Visa

Overview of comments received on Guideline on live recombinant vector vaccines for veterinary use - Revision 1

Reference Number: EMA/260063/2024

English (EN) (174.68 KB - PDF)

Först publicerad:
Visa

First version

Guideline on live recombinant vector vaccines for veterinary use

Adopted Reference Number: EMEA/CVMP/004/04-FINAL Legal effective date:

English (EN) (49.66 KB - PDF)

Först publicerad: Senast uppdaterad:
Visa

Concept paper for the revision of the guideline on live recombinant vector vaccines for veterinary use

Draft: consultation closed Consultation dates: to Reference Number: EMA/CVMP/IWP/161133/2023

English (EN) (158.52 KB - PDF)

Först publicerad:
Visa

Share this page